HSP70 overload causes immune tolerance to tumor antigens, which aids in the progression of tumors, while the initial release of HSP70 acts as a tumor suppressant that causes the killing of membrane-positive HSP70 tumor cells by NK cells to explain conflicting findings regarding the expression of HSP in cancer. Here, HSP90B2P is linked to cancer.